An Overview of New Strategies Based on Functional Nanoscale Materials to the Treatment of Tuberculosis
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18470%2F21%3A50019089" target="_blank" >RIV/62690094:18470/21:50019089 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1007/978-3-030-62226-8_19" target="_blank" >http://dx.doi.org/10.1007/978-3-030-62226-8_19</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/978-3-030-62226-8_19" target="_blank" >10.1007/978-3-030-62226-8_19</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
An Overview of New Strategies Based on Functional Nanoscale Materials to the Treatment of Tuberculosis
Popis výsledku v původním jazyce
Tuberculosis (TB) is a serious infectious disease of chronic evolution caused by Mycobacterium tuberculosis (MTB). In general, TB control depends on many factors, among which a fast and accurate diagnosis is essential, which in turn makes it possible to carry out a complete treatment involving the proper administration of medications by patients with active disease, that is, to prevent the transmission and evolution of this disease. Despite efforts to TB control, only in 2018, about 1.5 million people died for causes attributed to TB. This likely is due to the appearance of multidrug-resistant strains to known drugs, as well as individuals with HIV/AIDS who are more susceptible to TB. Thus, in this perspective, it is fundamentally important to develop new therapeutic options for the treatment of TB. Hence, this chapter aims to identify new therapeutic alternatives available in the scientific literature based on the use of functional nanoscale materials as strategies to control the increase in bacterial resistance to drugs commonly used in the treatment of TB. © 2021, The Author(s), under exclusive license to Springer Nature Switzerland AG.
Název v anglickém jazyce
An Overview of New Strategies Based on Functional Nanoscale Materials to the Treatment of Tuberculosis
Popis výsledku anglicky
Tuberculosis (TB) is a serious infectious disease of chronic evolution caused by Mycobacterium tuberculosis (MTB). In general, TB control depends on many factors, among which a fast and accurate diagnosis is essential, which in turn makes it possible to carry out a complete treatment involving the proper administration of medications by patients with active disease, that is, to prevent the transmission and evolution of this disease. Despite efforts to TB control, only in 2018, about 1.5 million people died for causes attributed to TB. This likely is due to the appearance of multidrug-resistant strains to known drugs, as well as individuals with HIV/AIDS who are more susceptible to TB. Thus, in this perspective, it is fundamentally important to develop new therapeutic options for the treatment of TB. Hence, this chapter aims to identify new therapeutic alternatives available in the scientific literature based on the use of functional nanoscale materials as strategies to control the increase in bacterial resistance to drugs commonly used in the treatment of TB. © 2021, The Author(s), under exclusive license to Springer Nature Switzerland AG.
Klasifikace
Druh
C - Kapitola v odborné knize
CEP obor
—
OECD FORD obor
20501 - Materials engineering
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název knihy nebo sborníku
Functional Properties of Advanced Engineering Materials and Biomolecules
ISBN
978-3-030-62225-1
Počet stran výsledku
24
Strana od-do
567-590
Počet stran knihy
780
Název nakladatele
Springer Science and Business Media B.V.
Místo vydání
Cham
Kód UT WoS kapitoly
—